RBC Bioscience Corporation (TPEX:6848)
Taiwan · Delayed Price · Currency is TWD 20.60
+0.90 (4.57%)
Jun 12, 2026, 1:50 PM CST
RBC Bioscience Market Cap
RBC Bioscience has a market cap or net worth of 281.19 million as of June 12, 2026. Its market cap has increased by 21.40% in one year.
Market Cap
281.19M
Enterprise Value
635.92M
Revenue
219.71M
Ranking
n/a
PE Ratio
12.01
Stock Price
20.60
Market Cap Chart
Since October 25, 2021, RBC Bioscience's market cap has decreased from 632.27M to 281.19M, a decrease of -55.53%. That is a compound annual growth rate of -16.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 281.19M | 16.91% |
| Dec 31, 2025 | 240.51M | -2.96% |
| Dec 31, 2024 | 247.83M | 17.90% |
| Dec 29, 2023 | 210.20M | 2.21% |
| Dec 30, 2022 | 205.66M | -55.24% |
| Dec 30, 2021 | 459.45M | -27.33% |
| Oct 25, 2021 | 632.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NatureWise Biotech & Medicals | 827.24M |
| MegaPro Biomedical | 796.07M |
| Neith | 791.43M |
| BioLASCO Taiwan | 768.36M |
| SynCore Biotechnology Co.,Ltd | 720.87M |
| TaiwanJ Pharmaceuticals | 607.32M |
| Vectorite Biomedical | 569.03M |
| LAUNXP Biomedical | 543.62M |